HLA-C and neoplasm: MHC molecules or other inhibitory receptors that recognize the corresponding ligands are downregulated in tumor cells; however, NK cells are activated and subsequently kill tumor cells via the so-called ‘missing-self’ mechanism (Figure 1) (10).